Zealand Pharma A/s buy BiotechBee
Start price
01.10.24
/
70%
€109.30
Target price
31.12.27
€150.00
Performance (%)
-2.47%
End price
14.12.24
€106.60
Summary
This prediction ended on 14.12.24 with a price of €106.60. With a performance of -2.47%, the BUY prediction by BiotechBee finished with a loss. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Zealand Pharma A/s | -0.147% | -0.147% | -34.772% |
| iShares Core DAX® | 0,99 % | 8,31 % | 7,03 % |
| iShares Nasdaq 100 | 2,07 % | 16,77 % | 35,95 % |
| iShares Nikkei 225® | 2,27 % | 15,61 % | 46,57 % |
| iShares S&P 500 | 1,04 % | 11,08 % | 26,46 % |
According to BiotechBee what are the pros and cons of Zealand Pharma A/s for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Zealand Pharma A/s diskutieren
Buy mit Kursziel 150,0
In the thread Trading Zealand Pharma A/s
Buy beendet

